Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual MeetingGlobeNewsWire • 05/23/24
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual MeetingGlobeNewsWire • 05/23/24
Merus Announces Financial Results for the First Quarter 2024 and Provides Business UpdateGlobeNewsWire • 05/08/24
Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDACGlobeNewsWire • 05/06/24
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual MeetingGlobeNewsWire • 04/24/24
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024GlobeNewsWire • 04/08/24
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell EngagersBusiness Wire • 03/06/24
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business UpdateGlobeNewsWire • 02/28/24
Merus N.V. (MRUS) Surges 16.3%: Is This an Indication of Further Gains?Zacks Investment Research • 01/09/24
Wall Street Analysts See a 52.96% Upside in Merus N.V. (MRUS): Can the Stock Really Move This High?Zacks Investment Research • 12/28/23
Wall Street Analysts Think Merus N.V. (MRUS) Could Surge 87.71%: Read This Before Placing a BetZacks Investment Research • 12/12/23
Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023GlobeNewsWire • 11/26/23
Wall Street Analysts See an 85.36% Upside in Merus N.V. (MRUS): Can the Stock Really Move This High?Zacks Investment Research • 11/23/23
Wall Street Analysts Think Merus N.V. (MRUS) Could Surge 83.26%: Read This Before Placing a BetZacks Investment Research • 11/07/23
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business UpdateGlobeNewsWire • 11/02/23
Merus' Zeno Interim Data Continues to Demonstrate Robust and Durable Responses in NRG1+ CancerGlobeNewsWire • 10/23/23